Olatunji Kayode Aremu1
,
Josiah Ademola Onaolapo2,
Yakubu Kokori Ibrahim2,
Igwe J Chibueze3
For correspondence:- Olatunji Aremu Email: olatunji.aremu@fuoye.edu.ng Tel:08033116140
Received: 24 March 2026 Accepted: 15 August 2026 Published: 31 August 2026
Citation: Aremu OK, Onaolapo JA, Ibrahim YK, Chibueze IJ. Incidence of vancomycin-resistant Staphylococcus aureus from clinical isolates in a tertiary health facility in Northern Nigeria. Trop J Pharm Res 2026; 25(8):1143-1151 doi: https://dx.doi.org/10.4314/tjpr.v25i8.11
© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Purpose: To evaluate the presence of genes associated with vancomycin resistance among S. aureus isolates recovered from clinical specimens collected in a hospital setting and to assess the possibility of S. aureus harboring genes that encode resistance to vancomycin in that setting. Methods: Clinical samples of S. aureus were obtained at the Department of Medical Microbiology Laboratory of Ahmadu Bello Teaching Hospital, Shika, Zaria. Determination of vancomycin resistance and the confirmatory test were done using the broth dilution method and Brain Heart Infusion (BHI) agar plates incorporated with 4 and 8 µg/mL vancomycin, respectively. Confirmation of the presence of the vancomycin resistance genes was carried out and serial culturing in an antibiotics free media was used to determine the phenotypic characteristics of the isolates. Results: The study showed that 25 % (36/144) of the S. aureus isolates were resistant to 30 µg vancomycin disc. Sixty-five (45.1 %) vancomycin-resistant Staphylococcus aureus (VRSA) were observed and the VRSA were hetero-resistant, having grown in BHI agar incorporated with 4 µg/mL and 8 µg/mL of vancomycin. Genes that are responsible for vancomycin resistance were not found, but it was observed that with increasing serial dilution, greater proportion of the previously resistant isolates became susceptible and the minimum inhibitory concentrations (MICs) of those that were still within the resistant range were discovered to be lower compared to the pre-serial dilution values. Conclusion: This study isolated S. aureus that exhibited intermediate and resistant phenotypic characteristics to vancomycin in an environment where vancomycin is not commonly prescribed.